Company intelligence / Profile preview

Resilience

San Diego, California, United Statesresilihealth.com ↗

Ownership: Private
Development stage: Other

Overview

Resilience is a leading North American technology-focused biomanufacturing CDMO founded in 2020. It provides end-to-end solutions for the development and scalable production of complex medicines—including biologics, vaccines, nucleic acids, cell therapies, and gene therapies—serving clients from early-stage to commercial supply. The company operates multiple state-of-the-art facilities across the US and Canada with regulatory capabilities spanning global markets. Its mission is to increase access to advanced therapies by revolutionizing how they are manufactured through innovative platforms and flexible business models[2][3][4].

Modalities: BiologicsVaccinesNucleic acidsCell therapyGene therapy
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Resilience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resilience.

Explore the full profile